Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Accentures Stock Price Targets Continue to Rise

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Finances-and-tech
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Accenture’s stock is on the rise as Wedbush has increased its price target to $400, following a previous raise from Bank of America to $419.00. This latest bump comes after Wedbush Securities raised the target from $330 to $360 on December 14, 2023. Analysts have provided a variety of price targets for Accenture, with an average target of $379.682 and forecasts ranging from $323.2 to $462. The consensus average target is currently at $386.8, with a high estimate of $426.00 and a low estimate of $360.00.

ACN Stock Shows Strong Performance on March 12, 2024: Price Momentum and Potential for Success

On March 12, 2024, ACN stock showed strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. The price of ACN shares increased by $7.01, a 1.88% rise from the previous market close. ACN opened at $377.55, which was $4.32 higher than its previous close. This opening price indicated a positive start for the stock and set the tone for a potentially successful trading day. Overall, the price momentum and price change on March 12th indicate that ACN stock had a strong performance. Investors may have been reacting positively to news or developments related to the company, prompting the increase in share price. It’s important for investors to continue monitoring ACN stock to see if this positive momentum continues in the days and weeks ahead.

ACN Stock Performance Analysis: Revenue Increases, Net Income Up 44%

ACN stock had a mixed performance on March 12, 2024. According to data from CNN Money, ACN reported a total revenue of $64.11 billion for the past year, which was a 4.09% increase compared to the previous year. The total revenue remained flat at $16.22 billion since the last quarter. ACN reported a net income of $6.87 billion for the past year, consistent with the previous year, but the net income increased by 43.74% to $1.97 billion in the first quarter of the current year. Earnings per share (EPS) for ACN stood at $10.77 for the past year, unchanged compared to the previous year, but increased by 44.15% to $3.10 in the first quarter of the current year. Investors may interpret these results differently, with some seeing the increase in net income and EPS as positive signs for the company’s future performance, while others may be concerned about the flat total revenue compared to the previous quarter.

Tags: ACN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Unlocking Value: The Economic Potential of Iron-Titanium-Vanadium Projects

Goldman Sachs Analyst Reaffirms Sell Rating on Franklin Resources

Healthcare Services Stock Exchange

Universal Health Services NYSE UHS Upgraded to Sector Perform with Increased Price Target

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Title Analysis of Options Trading Activity for Riot Platforms NASDAQ RIOT on March 12 2024

Recommended

Alphabet Stock

Alphabet Shares Surge as Antitrust Victory Sparks Market Rally

7 months ago
Invesco DB US Dollar Index Bullish Fund Stock

Geopolitical Tensions Fuel Dollar Strength and Spotlight on Invesco’s Bullish ETF

2 weeks ago
BayWa Stock

BayWa Faces Multifaceted Crisis as Restructuring Plan Unravels

3 days ago
Merit Medical Stock

Merit Medical Shares Await Key Catalysts for Momentum Shift

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

PagerDuty Charts a New Course with Autonomous AI Systems

Lexaria Bioscience Targets Multi-Billion Dollar Market with Side-Effect Solution

Watsco’s Dividend Hike Contrasts with Operational Headwinds

Trending

Talphera Stock
Analysis

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

by Jackson Burston
March 25, 2026
0

Despite reporting operational headway and a narrower-than-expected quarterly loss, Talphera's stock experienced significant selling pressure. The market's...

Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Technology Select Sector SPDR® Fund Stock

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026
Lumen Stock

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

March 25, 2026
Microsoft Stock

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress
  • Hain Celestial Sheds Snack Division in Strategic Overhaul
  • Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com